Vident Investment Advisory’s Select Medical SEM Stock Holding History

Vident Investment Advisory’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-103,136	Closed	-$1.63M	–	1339
2021 Q4	$1.63M	Buy	103,136 +4,245	+4%	+$72.5K	0.04%	538
2021 Q3	$1.93M	Sell	98,891 -16,727	-14%	-$332K	0.06%	434
2021 Q2	$2.63M	Sell	115,618 -445	-0.4%	-$9.23K	0.08%	290
2021 Q1	$2.13M	Buy	+116,063	New	+$1.9M	0.07%	347
2015 Q4	–	Sell	-72,527	Closed	-$422K	–	767
2015 Q3	$422K	Buy	72,527 +10,622	+17%	+$78.8K	0.06%	597
2015 Q2	$540K	Sell	61,905 -194,197	-76%	-$1.63M	0.07%	457
2015 Q1	$2.05M	Buy	256,102 +211,859	+479%	+$1.58M	0.41%	23
2014 Q4	$343K	Buy	+44,243	New	+$323K	0.12%	420

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vident Investment Advisory's SEM Position: Q1 2022 in Review

Vident Investment Advisory sold out of Select Medical (SEM) in Q1 2022, closing a stake of 103,136 shares — an estimated $1.63M sold.

Vident Investment Advisory first reported a position in SEM in Q4 2014 and held it in 8 quarters. The position peaked at $2.63M in Q2 2021. 240 funds tracked by Wall St. Rank hold SEM as of Q1 2022.

Vident Investment Advisory reported no remaining Select Medical position as of Q1 2022 after selling out during the quarter.
Vident Investment Advisory sold 103,136 Select Medical shares in Q1 2022, an estimated $1.63M.
Vident Investment Advisory first reported a position in Select Medical in Q4 2014 and held it in 8 quarters.
Vident Investment Advisory's Select Medical position peaked at $2.63M in Q2 2021.
240 funds tracked by Wall St. Rank held Select Medical as of Q1 2022.

Based on Vident Investment Advisory's 13F filing for Q1 2022, filed 16 May 2022.